Compare RXST & HPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RXST | HPI |
|---|---|---|
| Founded | 1997 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 524.6M | 436.8M |
| IPO Year | 2021 | N/A |
| Metric | RXST | HPI |
|---|---|---|
| Price | $9.80 | $16.26 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $11.30 | N/A |
| AVG Volume (30 Days) | ★ 889.0K | 64.7K |
| Earning Date | 02-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.97% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $142,085,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.12 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 10.75 | N/A |
| 52 Week Low | $6.32 | $12.85 |
| 52 Week High | $34.71 | $16.83 |
| Indicator | RXST | HPI |
|---|---|---|
| Relative Strength Index (RSI) | 42.05 | 38.19 |
| Support Level | $9.43 | $16.15 |
| Resistance Level | $10.96 | $16.34 |
| Average True Range (ATR) | 0.58 | 0.10 |
| MACD | -0.09 | 0.02 |
| Stochastic Oscillator | 48.30 | 47.83 |
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
John Hancock Preferred Income Fund is a closed-end, diversified management investment company. Its primary investment objective is to provide a high-level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve its investment objectives by investing in securities that may be undervalued relative to similar securities in the marketplace. The fund's principal investment strategies include investing a majority of its assets in preferred stocks and other preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, and short-term investments.